Background: Multiple
studies have reported on the safety of nipple-sparing mastectomy and low
complication rates associated with single-stage implant breast reconstruction.
Yet many plastic surgeons continue to be resistant to change. This article
presents the senior author’s (M.A.C.) experience during his transition period
from the latissimus dorsi flap with adjustable implants to a “one-and-done”
approach using shaped implants and fetal bovine acellular dermal matrix.
Methods: A literature review was performed selecting articles discussing
single-stage implant reconstruction, indications, outcomes, technique, and
complications. Additional articles were selected after review of the references
of identified articles. Clinical pearls discussed include patient selection,
implant selection, and mastectomy incision choices, with a detailed description
of the senior author’s operative technique. Results: Twenty-seven single-stage
implant reconstructions were performed. Average mastectomy weight was 343.82 g.
The average implant volume was 367 cc. Shaped implants were most commonly used.
Acellular dermal matrix was used in all breasts. Complications included
erythema requiring intravenous antibiotics (three patients), skin ischemia
caused by methylene blue (one patient), seroma (one patient), unilateral
partial nipple necrosis (one patient), mastectomy skin necrosis (one patient),
and exposed/infected implants that were salvaged using a sequential irrigation
protocol described by Sforza et al. in 2014 (two patients). Conclusions: Breast
reconstruction after mastectomy has evolved toward less invasive, single-stage
procedures. Aesthetic refinements include nipple-sparing mastectomy, use of
acellular dermal matrix, shaped implants, and fat grafting. Selected patients
will benefit from a one-and-done breast implant reconstruction with no
additional oncologic risk. Surgeons must embrace the change and provide their
patients with a procedure that will offer the best aesthetic outcomes.